Abstract:Abstract Introduction The Autologous Cell Harvesting Device is a medical device designed for regenerative medicine applications. Its primary function is to enable clinicians to prepare an autologous skin cell suspension (ASCS) from a small sample of a patient's skin at the point of care. This innovative approach allows for the use of a patient's own skin cells in various medical procedures. The ASCS device received Food and Drug Administration (FDA) approval in September 2018 for the treatment of acute thermal burn wounds, demonstrating ASCS as an effective tool for promoting tissue regeneration and wound healing while significantly reducing donor skin requirements. This study was designed to evaluate safety and effectiveness of ASCS in conjunction with widely meshed autografts in patients undergoing reconstruction of full-thickness, non-thermal skin defects such as those resulting from trauma and surgery. Methods This prospective, randomized, within-subject study enrolled patients ≥5 years of age with acute non-thermal full-thickness skin wounds requiring autografting. Investigators were responsible for their respective autografting plans for closure in alignment with their stand of care. Comparable treatment areas of >80 cm2 each were randomized to receive autografting treatment per investigator’s pre-identified plan (Control), or ASCS treatment in combination with a more widely meshed autograft than that of the Control. Co-primary effectiveness endpoints included 100% healing at (or prior to) 8 weeks post-treatment confirmed at 2 consecutive study visits at least 2 weeks apart, and the ratio of donor site to treatment area expansion ratios. Results Of the 65 patients enrolled, 63% (n = 41) had surgical skin defects while 37% (n = 24) had traumatic skin defects. Week 8 healing of the ASCS-treated areas (65%) was non-inferior to the Control areas (58%) (p < 0.025) and donor skin sparing in the ASCS-treated was superior to the Control area, using 27% less donor skin, on average (p < 0.025), meeting both co-primary endpoints. Conclusions ASCS application combined with a widely meshed autograft for the treatment of non-thermal full-thickness wounds required significantly less donor skin for closure and had comparable healing outcomes when compared to standard of care. The Autologous Cell Harvesting Device demonstrated its effectiveness in soft tissue wound repair by reducing the amount of donor skin and maintaining consistent healing outcomes. Applicability of Research to Practice The Autologous Cell Harvesting Device offers a clinically advantageous approach to autografting by reducing the amount of skin needed for closure without compromise to healing outcomes.

Efficacy of autologous micrografts technology: a promising approach for chronic wound healing and tissue regeneration—a pilot study

Preclinical Optimization of a Shelf-Ready, Injectable, Human-Derived, Decellularized Allograft Adipose Matrix.

Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration

The Role of Adipose-Derived Stem Cells, Dermal Regenerative Templates, and Platelet-Rich Plasma in Tissue Engineering-Based Treatments of Chronic Skin Wounds

Fat grafting and platelet-rich plasma in wound healing: a review of histology from animal studies

[The Clinical Application of Xenogenic (porcine) Acellular Dermal Matrix Grafting with Thin Autogenic Skin on Deep Wounds].

Fragmented Dermo-Epidermal Units (FdeU) as an Emerging Strategy to Improve Wound Healing Process: An In Vitro Evaluation and a Pilot Clinical Study

Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi‐centre clinical trial with a microvascular tissue allograft

Peripheral Blood Mononuclear Cells (PB-MNCs) for the treatment of chronic tissue dystrophy in a complex case of lower limb reconstruction

Adipose Autologous Micrograft and Its Derived Mesenchymal Stem Cells in a Bio Cross-Linked Hyaluronic Acid Scaffold for Correction Deep Wrinkles, Facial Depressions, Scars, Face Dermis and Its Regenerations: A Pilot Study and Cases Report

Assessment of the quality of the healing process in experimentally induced skin lesions treated with autologous platelet concentrate associated or unassociated with allogeneic mesenchymal stem cells: preliminary results in a large animal model

One-Year Analysis of Autologous Peripheral Blood Mononuclear Cells as Adjuvant Therapy in Treatment of Diabetic Revascularizable Patients Affected by Chronic Limb-Threatening Ischemia: Real-World Data from Italian Registry ROTARI

Acellular Biomaterials Associated with Autologous Bone Marrow-Derived Mononuclear Stem Cells Improve Wound Healing through Paracrine Effects

Multi-faceted enhancement of full-thickness skin wound healing by treatment with autologous micro skin tissue columns

Autologous Fat Grafting—A Panacea for Scar Tissue Therapy?

80 Donor Skin Reduction in Full-thickness Wounds Using Autologous Cell Harvesting Device with Meshed Autograft

Nanofat Accelerates and Improves the Vascularization, Lymphatic Drainage and Healing of Full-Thickness Murine Skin Wounds

Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects

Secretome of Adipose Tissue-Derived Stem Cells (ASCs) as a Novel Trend in Chronic Non-Healing Wounds: An Overview of Experimental In Vitro and In Vivo Studies and Methodological Variables

Wound Healing: In Vitro and In Vivo Evaluation of a Bio-Functionalized Scaffold Based on Hyaluronic Acid and Platelet-Rich Plasma in Chronic Ulcers

Microvascular fragment-loaded platelet-rich plasma dressing promotes cutaneous wound healing